SOLIGO, DAVIDE
SOLIGO, DAVIDE
DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)
RAS mutations vontribute to evolution of chronic myelomonocytic leukemia to the proliferative variant
2010 F. Onida, C. Ricci, E. Fermo, C. Miranda, S. Corti, A. Cortelezzi, A. Faricciotti, D. Soligo, G. Lambertenghi Deliliers
Molecular and phenotypical characterization of human amniotic fluid cells and their differentiation potential
2008 T. Montemurro, P. Bossolasco, L. Cova, S. Zangrossi, C. Calzarossa, S. Buiatiotis, D. Soligo, V. Silani, G. Lambertenghi Deliliers, P. Rebulla, L. Lazzari
Neuroprotective potential of human mesenchymal stem cells in a rodent model of Parkinson's disease
2007 M.T. Armentero, E. Zennaro, L. Cova, G. Levandis, C. Calzarossa, P. Bossolasco, M. Mellone, G. Lambertenghi-Deliliers, E. Polli, V. Silani, F. Blandini, D. Soligo
Human adult mesenchymal stem cells potential in a Parkinsonian animal model
2007 L. Cova, M. Armentero, E. Zennaro, G. Levandis, C. Calzarossa, P. Bossolasco, D. Soligo, G. Lambertenghi Deliliers, E. Polli, F. Blandini, V. Silani
Multilineage potential of human amniotic fluid cells
2007 T. Montemurro, P. Bossolasco, L. Cova, V. Lo Cicero, G. Andriolo, D. Soligo, V. Silani, G. Lambertenghi Deliliers, P. Rebulla, L. Lazzari
Mesenchymal stem cell as a tool for cell theraphy in a rodent model of Parkinson's disease (6-hydroxydopamine-induced neuronal lesion): an in vitro characterization and toxicity study
2007 C. Calzarossa, E. Zennaro, P. Bossolasco, M.T. Armentero, L. Cova, D. Soligo, G. Lambertenghi Deliliers, E. Polli, F. Blandini, V. Silani
Human mesenchymal stem cell implant in a rodent Parkinson's model : preliminary results from an in vitro and in vivo study
2007 L. Cova, M.T. Armentero, E. Zennaro, P. Bossolasco, C. Calzarossa, G. Levandis, D. Soligo, G. Lambertenghi Deliliers, E. Polli, F. Blandini, V. Silani
Neuroprotective potential of human mesenchymal stem cells in a rodent model of Parkinson's disese
2007 M.T. Armentero, L. Cova, E. Zennaro, G. Levandis, C. Calzarossa, P. Bossolasco, M. Mellone, D. Soligo, G. Lambertenghi-Deliliers, E. Polli, V. Silani, F. Blandini
Human bone marrow mesenchymal stem cells transplantation in 6-hydroxydopamine-lesioned rodents
2007 P. Bossolasco, E. Zennaro, M.T.H. Armentero, L. Cova, C. Calzarossa, G. Levandis, M. Mellone, F. Blandini, D. Soligo, F. Onida, V. Silani, G. Lambertenghi Deliliers, E. Polli
Induction of neurotrophin expression via human adult mesenchymal stem cells : implication for cell therapy in neurodegenerative diseases
2007 F. Pisati, P. Bossolasco, M. Meregalli, L. Cova, M. Belicchi, M. Gavina, C. Marchesi, C. Calzarossa, D. Soligo, G. Lambertenghi-Deliliers, N. Bresolin, V. Silani, Y. Torrente, E. Polli
Hematological, molecular and cytokine changes after reduced intensity bone marrow transplantation for paroxysmal nocturnal hemoglobinuria
2007 W. Barcellini, E. Fermo, F.G. Imperiali, A. Zaninoni, C. Boschetti, F. Onida, D. Soligo
Human adult mesenchymal stem cell neuroprotective potential to support neurons' survival
2007 V. Silani, M. Armentero, E. Zennaro, G. Levandis, C. Calzarossa, P.M. Bossolasco, M. Mellone, L. Cova, D. Soligo, G. Lambertenghi Deliliers, E. Polli, F. Blandini
Indeterminate cell histiocytosis in association with later occurrence of acute myeloblastic leukaemia
2007 C. Vener, D. Soligo, E. Berti, U. Gianelli, F. Servida, E. Ceretti, R. Caputo, E. Passoni, G. Lambertenghi Deliliers
Indeterminate cell histiocytosis evolving into acute myelogenous leukaemia
2006 C. Vener, D. Soligo, E. Berti, U. Gianelli, F. Servida, E. Ceretti, R. Caputo, E. Passoni, G. Lambertenghi Deliliers
Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation
2006 M. Viganò, C. Vener, D. Soligo, M. Colombo, F. Lanfranchi, G. Lambertenghi Deliliers, P. Lampertico
Hepatitis B virus reverse seroconversion in allogeneic hematopoietic stem cell transplantation
2006 C. Vener, D. Soligo, M. Viganò, P. Lampertico, M. Colombo, F. Lanfranchi, G. Lambertenghi Deliliers
Sphingosine Kinase 1 is involved in survival and proliferation of myeloid leukemia cells, representing a potential novel target for treatment
2006 C. Ricci, F. Onida, G. Sala, F. Radaelli, D. Soligo, R. Ghidoni, G. Lambertenghi Deliliers
Involvement of RAS, JAK2 and GM-CSF in the pathogenesis of proliferative variant of chronic myelomonocytic leukaemia
2006 F. Onida, F. Servida, C. Ricci, E. Fermo, M.C. Pasquini, A. Vismara, A. Cortelezzi, S. Soligo, G. Lambertenghi Deliliers
In vitro cultures support histological parameters in the identification of different subsets of myelofibrosis with myeloid metaplasia (MMM)
2006 F. Servida, D. Soligo, C. Vener, V. Tubazio, U. Gianelli, R. Calori, F. Onida, G. Lambertenghi Deliliers
Clinical and histopathological features of oral chronic graft-versus-host disease following allogenic reduced-intensity conditioning haematopoietic stem cell transplantation: a single-centre blind study
2006 F. Demarosi, D. Soligo, A. Carrassi, F. Onida, G. Lodi, L. Moneghini, A. Sardella